1. Home
  2. ANIK vs AVR Comparison

ANIK vs AVR Comparison

Compare ANIK & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIK
  • AVR
  • Stock Information
  • Founded
  • ANIK 1983
  • AVR 1999
  • Country
  • ANIK United States
  • AVR Australia
  • Employees
  • ANIK N/A
  • AVR N/A
  • Industry
  • ANIK Medical/Dental Instruments
  • AVR
  • Sector
  • ANIK Health Care
  • AVR
  • Exchange
  • ANIK Nasdaq
  • AVR NYSE
  • Market Cap
  • ANIK 157.8M
  • AVR 162.1M
  • IPO Year
  • ANIK 1993
  • AVR 2024
  • Fundamental
  • Price
  • ANIK $8.64
  • AVR $3.07
  • Analyst Decision
  • ANIK Buy
  • AVR Strong Buy
  • Analyst Count
  • ANIK 1
  • AVR 4
  • Target Price
  • ANIK $15.00
  • AVR $16.50
  • AVG Volume (30 Days)
  • ANIK 156.3K
  • AVR 199.6K
  • Earning Date
  • ANIK 07-30-2025
  • AVR 08-16-2025
  • Dividend Yield
  • ANIK N/A
  • AVR N/A
  • EPS Growth
  • ANIK N/A
  • AVR N/A
  • EPS
  • ANIK N/A
  • AVR N/A
  • Revenue
  • ANIK $114,548,000.00
  • AVR $2,493,000.00
  • Revenue This Year
  • ANIK N/A
  • AVR $33.26
  • Revenue Next Year
  • ANIK $9.70
  • AVR $194.42
  • P/E Ratio
  • ANIK N/A
  • AVR N/A
  • Revenue Growth
  • ANIK 4.60
  • AVR N/A
  • 52 Week Low
  • ANIK $7.87
  • AVR $2.34
  • 52 Week High
  • ANIK $27.50
  • AVR $8.79
  • Technical
  • Relative Strength Index (RSI)
  • ANIK 32.85
  • AVR N/A
  • Support Level
  • ANIK $7.87
  • AVR N/A
  • Resistance Level
  • ANIK $11.61
  • AVR N/A
  • Average True Range (ATR)
  • ANIK 0.67
  • AVR 0.00
  • MACD
  • ANIK -0.29
  • AVR 0.00
  • Stochastic Oscillator
  • ANIK 20.59
  • AVR 0.00

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Share on Social Networks: